The mechanism of EZH2/H3K27me3 downregulating CXCL10 to affect CD8 + T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20066 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Zhuanzhen Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hemapathotology, Second Hospital of Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Chemokine CXCL10, Enhancer of Zeste Homolog 2 Protein, CD8-Positive T-Lymphocytes, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Shanxi Province Applied Basic Research: Natural Science Foundation.
Abstract (Originalsprache)
Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) link to unfavourable prognoses. We explored the mechanism of enhancer of zeste homologue 2/histone H3 of lysine 27 (EZH2/H3K27me3) downregulating C‐X‐C motif chemokine 10 (CXCL10) to affect CD8 + T‐cell exhaustion, participating in MDS‐to‐AML transformation. NHD13 mice were treated with GSK126 (EZH2 inhibitor) and CXCL10 neutralizing antibody, with transformation time, blood cell counts and CD8 + T cell determined. SKM‐1 cells treated with short hairpin‐ EZH2 , overexpressing‐ EZH2 , GSK126 and CXCL10 were co‐cultured with CD8 + T cells. EZH2, CXCL10, H3K27me3 and EZH2 levels and EZH2 enzyme activity were assessed. CD8 + T‐cell cytotoxicity, exhaustion, apoptosis and SKM‐1 cell malignant behaviours were evaluated. In vivo, EZH2 inhibition upregulated CXCL10, decelerating MDS to AML transformation and delaying CD8 + T‐cell exhaustion. EZH2 inhibition elevated peripheral blood cells, alleviated splenomegaly, reduced CD8 + T cells, elevated CD8 + T cytotoxicity and abated CD8 + T‐cell exhaustion in NHD13 mice. CXCL10 neutralizing antibody accelerated AML transformation by inhibiting CD8 + T‐cell exhaustion via EZH2. In vitro, EZH2 overexpression facilitated CD8 + T‐cell exhaustion and SKM‐1 cell malignant behaviours. EZH2‐mediated H3K27me3 curbed CXCL10 transcription and secretion. Collectively, EZH2/H3K27me3 downregulates CXCL10 to facilitate CD8 + T‐cell exhaustion, accelerating transformation from MDS to AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hemapathotology, Second Hospital of Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Zhuanzhen Zheng
Förderung
- Shanxi Province Applied Basic Research: Natural Science Foundation
Zitieren
APA
Zheng, Z., Wang, W., Feng, M., Chen, X., Ren, F., & Hou, Y. (2025). The mechanism of EZH2/H3K27me3 downregulating CXCL10 to affect CD8 + T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.20066
Vancouver
Zheng Z, Wang W, Feng M, Chen X, Ren F, Hou Y. The mechanism of EZH2/H3K27me3 downregulating CXCL10 to affect CD8 + T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia. British Journal of Haematology. 2025. doi:10.1111/bjh.20066
BibTeX
@article{Zheng2025,
author = {Zheng, Zhuanzhen and Wang, Wenjing and Feng, Mengjing and Chen, Xiuhua and Ren, Fanggang and Hou, Yanfei},
title = {The mechanism of EZH2/H3K27me3 downregulating CXCL10 to affect CD8 + T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20066}
}
EUVIMED